Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2010
10/06/2010EP1689726B1 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
10/06/2010EP1537091B1 Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
10/06/2010CN1942186B Pyrrolidine compounds
10/06/2010CN101855215A Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
10/06/2010CN101851199A Substituted piperazine N-ethyl sulfonamide derivative and preparation and application thereof
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807710 epothilone-like derivates used as anticarcinotgenic and antitumor agents
10/05/2010US7807700 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807690 such as 2-(3-aminopyridin-2-yl)-5-[(1-imino-2,3-dihydro-1H-isoindol-5-ylamino)-(8-methoxy-4H-benzo[1,3]dioxin-6-yl)methyl]-2,4-dihydro-1,2,4-triazol-3-one, having serine protease inhibiting activity, and particularly excellent inhibiting activity against blood-coagulation factor VIIa
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807672 Compounds that are ERK inhibitors
10/05/2010US7807670 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010CA2400479C Platelet adp receptor inhibitors
10/05/2010CA2352679C Process for the preparation of 3-aryl-benzofuran-2-ones
09/2010
09/30/2010WO2010111718A2 Antiviral compounds and methods of use thereof
09/30/2010WO2010111572A1 Compounds as cannabinoid receptor ligands
09/30/2010WO2010111460A1 Inhibitors of nf-kb
09/30/2010WO2010110414A1 Indazolepropionic acid amide compound
09/30/2010WO2010110231A1 Substituted 3-hydroxy-4-pyridone derivative
09/30/2010WO2010109123A1 Anticancer derivatives, preparation thereof, and therapeutic use thereof
09/30/2010WO2010108733A1 Insecticidal compounds
09/30/2010WO2010108608A1 Substituted piperidines as par-1 antagonists
09/30/2010WO2010089510A3 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
09/30/2010US20100249402 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteporosis comprising the same
09/30/2010US20100249201 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation
09/30/2010US20100249198 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249163 Renin inhibitors
09/30/2010US20100249129 Compounds as cannabinoid receptor ligands
09/30/2010US20100249099 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
09/30/2010US20100249098 Oxypiperidine derivatives and methods of use thereof
09/30/2010US20100249097 Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
09/30/2010US20100249094 Compounds for the Treatment of Hepatitis C
09/30/2010US20100249092 Heteroaryl compounds and uses thereof
09/30/2010US20100249088 Azolecarboxamide compound or salt thereof
09/30/2010US20100249087 Compounds as cannabinoid receptor ligands
09/30/2010US20100249078 Tetracyclic inhibitors of fatty acid amide hydrolase
09/30/2010US20100249071 Modulators of S1P and Methods of Making And Using
09/30/2010US20100249049 Arylalkylamine compound and process for preparing the same
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010DE102009014484A1 Substituierte Piperidine Substituted piperidines
09/30/2010CA2756178A1 Compounds as cannabinoid receptor ligands
09/30/2010CA2756005A1 Substituted piperidines as par-1 antagonists
09/30/2010CA2755910A1 Inhibitors of nf-kb
09/29/2010EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation.
09/29/2010EP2233474A1 Condensed aminodihydrothiazine derivative
09/29/2010EP2233472A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
09/29/2010EP2231681A1 Additive composition for ep greases with excellent antiwear and corrosion properties
09/29/2010EP2231656A1 Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
09/29/2010EP2231655A2 4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl)benzenesulfonamide derivati ves and related compounds as modulators of ion channels for the treatment of pain
09/29/2010EP2231654A1 Novel 2-substituted thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
09/29/2010EP2231653A1 Antibacterial condensed thiazoles
09/29/2010EP2231652A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament
09/29/2010EP2231640A1 Beta-amino acid derivatives for treatment of diabetes
09/29/2010EP2231629A1 Modulators for amyloid beta
09/29/2010EP2231625A1 Thiazole and oxazole kinase inhibitors
09/29/2010EP2231620A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
09/29/2010EP2004641B1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
09/29/2010EP1628957B1 Sulfopyrroles
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010EP1421074B1 Novel compounds
09/29/2010EP1399402B1 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
09/29/2010EP1313731B1 Thiazolidine derivatives and its use as antifungal agent
09/29/2010EP1086950B1 Heterocyclic indole derivatives and mono- or diazaindole derivatives
09/29/2010CN1816549B Inhibitors of phosphatidylinositol 3-kinase
09/29/2010CN101848908A Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
09/29/2010CN101848897A Gamma secretase modulators
09/29/2010CN101845044A New crystal forms of Abafungin and preparation method thereof
09/29/2010CN101845043A Ortho heterocycle formanilide compound and synthesis method and application thereof
09/29/2010CN101845029A 4-methyl-1,2,3-tiadiazoline-5-formic ether compounds and preparation method and application thereof
09/29/2010CN101240166B Bromobenzothiazoles luminous agent and preparation method thereof
09/29/2010CN101006082B Histamine H3 receptor agents, preparation and therapeutic uses
09/29/2010CN101006076B Modulators of ATP-binding cassette transporters
09/28/2010US7803944 Viral polymerase inhibitors
09/28/2010US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
09/28/2010US7803841 EP2 receptor agonists
09/28/2010US7803832 N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides
09/28/2010US7803823 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases
09/28/2010US7803819 dipeptidyl peptidase IV (DPP-IV) inhibitors, such as 2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile, useful for the treatment and/or prophylaxis non-insulin dependent diabetes and impaired glucose tolerance; antidiabetic agents
09/28/2010CA2553160C 2-heteroaryl-substituted benzimidazole derivative
09/28/2010CA2527587C Heteroaryl-substituted imidazole derivatives as glutamate receptor antagonists
09/28/2010CA2493765C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
09/28/2010CA2420302C Catalytic process for the preparation of thiazole derivatives
09/28/2010CA2395772C Sulfonamide-containing heterocyclic compounds
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/23/2010WO2010107965A1 Process for preparing sulfonyl quinolines
09/23/2010WO2010107736A2 Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
09/23/2010WO2010107384A1 Aspartyl protease inhibitors
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106081A1 Piperidine derivatives as nk3 receptor antagonists
09/23/2010WO2010106016A1 Pyrimidine derivatives used as itk inhibitors
09/23/2010WO2010073011A3 Heterocyclic compounds and their use as ampk activators
09/23/2010US20100240890 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
09/23/2010US20100240889 Urea Derivatives Methods For Their Manufacture And Uses Thereof
09/23/2010US20100240721 desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; stabilizing microtubules
09/23/2010US20100240715 Apoptosis promoters
09/23/2010US20100240709 Sulfoximine Derivatives as p38 MAP Kinase Inhibitors